2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody’s Ratings Agency Revises Outlook to Positive
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
– Significant commercial strategy and product launch experience –– ATTACK Phase 3 top-line data readout remains on-track for 2H 2021...
REDWOOD CITY, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company developing novel...
SOUTH SAN FRANCISCO, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments...
Grant Blouse, Ph.D., M.Sc. appointed chief scientific officer Tom Knudsen, DVM, Ph.D. promoted to senior vice president, corporate development Howard...
Nes Ziona, Israel, July 14, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming...
PRESS RELEASE July 14, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that...
HOUSTON, July 14, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc. (Coya), a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous...
Million-Cell Experiments Routinely Accessible for the First TimePLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Building on its industry leading...
Company Benefiting from Organic Growth as well as Cross-Pollination of Influencer Communities as Pace of Growth in Reach AcceleratesLOS ANGELES,...
National Expansion Continues With Entrance Into California, Missouri, Arkansas and Mississippi; $5.5 Million in Annualized Revenues, 10% Adjusted EBITDA Margin...
BOULDER, Colo., July 14, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (“the “Company” or “Viridian”), a biopharmaceutical company...
Collaboration combines Teladoc Health’s Solo platform and Microsoft Teams to integrate clinical and administrative medical office operationsPURCHASE, NY, July 14,...
Newly Created Role Demonstrates Company’s Commitment to Growth and Innovation as Industry Leader in Biopharmaceutical Product DevelopmentMORRISVILLE, N.C., July 14,...
BOWIE, Md., July 14, 2021 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare,...
Healthcare and financial services industry veteran brings nearly 15 years of multi-disciplinary financial experience and proven track record in strategic...
NEW YORK, July 14, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused...
TORONTO and CHICAGO, July 14, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an...
Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA...
CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel...
TORONTO, July 14, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the...
